Leading through complexity

This article is the third in a four-part series exploring the strategic concepts that matter most in today’s volatile, uncertain, complex and ambiguous (VUCA) market. Each piece distils a core idea that leaders in pharma, medtech and related sectors need to understand to adapt and compete.

Life sciences strategists operate in an environment where uncertainty is not a temporary inconvenience, but a structural feature of the industry. Scientific signals are ambiguous, regulatory guidance shifts, competitive environments are opaque and payer behaviour varies across markets and over time. All this in a market where commercial outcomes depend on complex interactions between scientific, clinical, economic and political forces that constantly adapt to each other.

Human brains didn’t evolve to cope with this combination of complexity and uncertainty, and are prone to distortions of strategic judgement. Even highly experienced leaders fall into predictable traps when interpreting weak signals, forecasting outcomes or making strategic decisions. The more uncertain the environment, the less well adapted to it we are. In VUCA conditions, our flaw is not ignorance, but misperception.

This is not a criticism of individuals. It is a description of how the human mind works. Our cognitive machinery evolved to make rapid judgements in environments where feedback was immediate and consequences were visible. The life sciences ecosystem is the opposite: feedback loops stretch over years, evidence is incomplete and the consequences of decisions are rarely clean cut. In such environments, human intuition becomes unreliable and experience, which is normally an asset, can become a liability when it anchors leaders to outdated heuristics and rules of thumb.

Answers to these problems can be found in the academic domain of behavioural strategy, the field that applies cognitive science to strategic decision-making and offers a way to counter these distortions. It does not promise certainty; nothing does – but it does offer leaders a disciplined way to reach clearer, more reliable conclusions when the evidence is incomplete and the stakes are high.ut you will have something that is authentic and resonates in their life and world.”

Behavioural strategy is best understood as a practical discipline that identifies and reduces the predictable errors that arise when humans make decisions under uncertainty. It draws on decades of research into cognitive biases, organisational noise and decision processes and, while academically rigorous, it is intensely pragmatic. Its aim is to help leadership teams think more clearly in the face of complexity.

In the life sciences industry, decisions are uniquely vulnerable to cognitive error because they involve weak signals, long feedback loops and high risk. Early scientific or regulatory cues can be interpreted in multiple ways. Commercial forecasts depend on assumptions about payer behaviour, competitor moves and clinical differentiation that may not be testable for years. And each function sees the world through its own lens, creating competing narratives that are difficult to reconcile.

These conditions create fertile ground for confirmation bias, optimism bias, anchoring, sunk-cost fallacy and groupthink. None of these is a failure of intelligence. They are failures of decision hygiene, the routines that shape how teams interpret evidence and reach conclusions.

Consider, for example, the familiar pattern of over-forecasting in launch planning. Teams extrapolate from surrogate endpoints, assume favourable payer responses and underestimate the competitive intensity of crowded indications.

Or consider the opposite pattern: underestimating the potential of a therapy in a rare disease because early signals are noisy, reimbursement is unpredictable and the organisation has limited experience in the area. In both cases, the problem is not the data, but the interpretation.

Just as dynamic capabilities operate through sensing, seizing and reconfiguring, and platform strategies through core, extension and governance, behavioural strategy operates through three mechanisms that counter the distortions of complexity: framing, challenge and calibration.

1. Framing: defining the decision before debating solutions
Most strategic errors begin with a poorly defined decision. Teams jump to evaluation before agreeing on which problem they are solving, which evidence matters, which assumptions are embedded and what success looks like. In VUCA environments, framing is the antidote to ambiguity. It forces clarity before analysis and prevents teams from debating different questions without realising it.

Framing also exposes the hidden assumptions that shape strategic conversations. A portfolio decision framed as ‘Which asset has the highest probability of technical success?’ will produce a different discussion from one framed as ‘Which asset strengthens our long-term competitive position?’. Both are legitimate questions, but they lead to different interpretations of the same evidence. Behavioural strategy begins by making these distinctions explicit.

2. Challenge: introducing disciplined dissent
High-stakes decisions require strong, but structured and effective challenge rather than groupthink. Effective leadership teams create mechanisms that surface dissent early and productively.

Pre-mortems, red-team/blue-team exercises and assumption audits are not some of the methods firms use to reveal hidden assumptions and expose overconfidence. Challenge counters complexity by making the implicit explicit.

In many organisations, dissent is encouraged by policy, but discouraged by culture. Teams fear appearing negative or obstructive and senior leaders unintentionally signal that enthusiasm is valued more than scepticism. Behavioural strategy reverses this dynamic by institutionalising challenge as a normal part of decision-making. It shifts the culture from ‘support the asset’ to ‘strengthen the decision’.

3. Calibration: improving judgement through feedback loops
Life sciences organisations rarely close the loop between decision and outcome. Forecasts are made, decisions are taken and the organisation moves on. Calibration requires tracking forecast accuracy, reviewing business development decisions against actual performance, learning from launch misreads and revisiting assumptions when evidence shifts. Over time, calibration builds a more realistic, less narrative-driven view of the world.

Calibration is particularly powerful because it transforms experience from a source of bias into a source of learning. Leaders begin to recognise their own patterns of overconfidence or pessimism. Teams learn which assumptions tend to hold and which tend to fail. And organisations develop a more grounded sense of what is genuinely predictable and what is not.

When situational complexity overwhelms strategic judgement, predictable patterns emerge. Evidence myopia leads teams to give more weight to the data they have and ignore the data they need. Political gravity pulls decisions towards the preferences of senior voices, regardless of evidence. Narrative capture seduces teams into believing the story they want to be true. And false precision creates confidence without clarity, as complex forecasts are expressed with spurious accuracy.

These patterns emerge because they are the natural consequences of human cognition operating in environments that exceed its design limits. Recognising them is the first step towards countering them.

The organisations that make consistently better decisions in VUCA environments rely on disciplined routines rather than superhuman intuition. They frame decisions clearly, introduce structured challenge early, make assumptions transparent, separate analysis from advocacy and calibrate their judgement over time by learning from their own decisions.

Even these routines can’t eliminate uncertainty, but they can make it navigable. In doing so, they create a competitive advantage that is difficult for rivals to copy because it is rooted not in purchasable assets or technologies, but in hard-to-imitate organisational behaviour.

Behavioural strategy also interacts with the concepts explored earlier in this series. Dynamic capabilities depend on accurate sensing and seizing; behavioural strategy improves both by reducing misinterpretation. Platform strategies depend on disciplined governance; behavioural strategy strengthens that governance by clarifying assumptions and exposing overreach. In this sense, behavioural strategy is not a standalone tool, but a foundational capability that underpins strategic clarity across the organisation.

Behavioural strategy is a capability demonstrated by only the best-led life sciences firms. Because, in VUCA environments, competitive advantage comes not from having more data, but from interpreting data more clearly than rivals, behavioural strategy gives leaders a way to reduce predictable errors, improve decision quality, strengthen important choices and avoid costly misreads.

Evolved for a different environment, the human mind is vulnerable to error unless leaders build the routines that counter it.

Box 5: Diagnostic questions for leadership teams